Compass Therapeutics

(NASDAQ) CMPX

Current Price$2.06

Market Cap$363.78M

Since IPO (2021)-76%

5 Year-59%

1 Year-23%

1 Month-2%

Compass Therapeutics Financials at a Glance

Market Cap

$363.78M

Revenue (TTM)

$0.00

Net Income (TTM)

-$68.17M

EPS (TTM)

-$0.41

P/E Ratio

-4.91

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$2.06

Volume

55,805

Open

$2.03

Price

$2.06

Volume

55,805

Open

$2.03

Previous Close

$2.02

Daily Range

$2.02 - $2.11

52-Week Range

$1.61 - $6.88

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$2.06

Volume

55,805

Open

$2.03

Previous Close

$2.02

Daily Range

$2.02 - $2.11

52-Week Range

$1.61 - $6.88

Estimated Earnings Date

Aug 10, 2026

CMPX News

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing

Jake LerchMar 2, 2026

Compass Therapeutics Posts Wider Q2 Loss

Motley Fool Markets TeamAug 11, 2025

CMPX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Compass Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas J. Schuetz, MD, PhD

Website

www.compasstherapeutics.com

Headquarters

Boston, MA 02135, US

CMPX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-39.75%

Return on Capital

-35.25%

Return on Assets

-33.23%

Earnings Yield

-20.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$363.78M

Shares Outstanding

180.09M

Volume

55.80K

Avg. Volume

7.80M

Financials (TTM)

Gross Profit

-$738.00K

Operating Income

-$75.17M

EBITDA

-$67.05M

Operating Cash Flow

-$53.20M

Capital Expenditure

-$89.00K

Free Cash Flow

-$53.29M

Cash & ST Invst.

$194.69M

Total Debt

$9.79M

Compass Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$368.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$363.78M

N/A

Market Cap/Employee

$10.39M

N/A

Employees

N/A

Net Income

-$18.32M

-10.1%

EBITDA

-$17.95M

-10.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$194.69M

+72.8%

Total Debt

$9.79M

+53.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$8.42M

+34.2%

Short Term Debt

$1.37M

+1159.6%

Return on Assets

-33.23%

N/A

Return on Invested Capital

-38.57%

N/A

Free Cash Flow

-$17.35M

-31.2%

Operating Cash Flow

-$17.27M

-30.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$3.96+0.01%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.37-1.32%

FULCFulcrum Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.$3.70-1.73%

MNPRMonopar Therapeutics Inc.

MNPRMonopar Therapeutics Inc.$88.17-0.92%

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$11.61-0.09%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.17+3.08%

OMEROmeros Corporation

OMEROmeros Corporation$10.57-0.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.47+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.41+0.03%

TECHBio-Techne

TECHBio-Techne$70.50+0.20%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.43+0.00%

FCUVFocus Universal

FCUVFocus Universal$5.68+0.29%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.74-0.00%

Questions About CMPX

What is the current price of Compass Therapeutics?

Compass Therapeutics is trading at $2.06 per share.

What is the 52-week range for Compass Therapeutics?

Over the past 52 weeks, Compass Therapeutics has traded between $1.61 and $6.88.

How much debt does Compass Therapeutics have?

As of the most recent reporting period, Compass Therapeutics reported total debt of $9.79M.

How much cash does Compass Therapeutics have on hand?

Compass Therapeutics reported $55.17M in cash and cash equivalents in its most recent financial results.

What is Compass Therapeutics’s dividend yield?

Compass Therapeutics does not currently have a dividend yield.

Compass Therapeutics

Compass Therapeutics Financials at a Glance

CMPX News

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing

Compass Therapeutics Posts Wider Q2 Loss

CMPX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Compass Therapeutics

CMPX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Compass Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CMPX

What is the current price of Compass Therapeutics?

What is the 52-week range for Compass Therapeutics?

How much debt does Compass Therapeutics have?

How much cash does Compass Therapeutics have on hand?

What is Compass Therapeutics’s dividend yield?

Premium Investing Services